Godavari Drugs — 360° view

Godavari Drugs, a company in the Pharmaceuticals industry, reported revenue of ₹28 crore and net profit of ₹0.96 crore for the September 2026 quarter.

Godavari Drugs (BSE: GODAVARI) closed at ₹118.95 on 20 Nov 2026, up 50.3% over the past year. Its market capitalisation is ₹130 crore and it trades at 33.7 times earnings.

Share price
₹118.95 (20 Nov 2026)
Market cap
₹130 Cr (20 Nov 2026)
P/E
33.72 (20 Nov 2026)
Revenue
₹28 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
6.55% (FY26)
ROE
6.14% (FY26)
Book value
₹76.2 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹144.35 / ₹69.70 (20 Nov 2026)
1-year return
50.3% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: GODAVARI

Incorporated in 1987, Godavari Drugs Ltd manufactures and sale of Active Pharmaceutical Ingredients and their intermediates

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.